Track Imugene Limited's total current liabilities ($14M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Imugene Limited (IMU.AX) currently reports a total current liabilities of $14M as of June 2026. That compares with $22M in the prior-year period — down 36.8% year over year. Use the charts on this page to explore Imugene Limited's total current liabilities history and peer comparisons.
Imugene Limited's total current liabilities decreased from $22M to $14M — a 36.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Imugene Limited reported $14M in total current liabilities as of June 2026. That compares with $22M in the prior-year period — down 36.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Imugene Limited, and consider following IMU.AX for alerts when major investors trade the stock.
Imugene Limited is classified in the Healthcare sector. On total current liabilities, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMU.AX with unrelated industries.